货号:A851897 同义名: GW257406X;1263W94
Maribavir是一种有效的野生型pUL97催化的组蛋白磷酸化抑制剂,IC50为3 nM。它对HCMV和Epstein-Barr病毒(EBV)具有强效的抗病毒活性。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Maribavir effectively inhibits the autophosphorylation of both wild-type and major Ganciclovir (GCV) resistant UL97 mutants, with an average IC50 of 35 nM. The M460I mutation exhibits increased sensitivity to Maribavir, having an IC50 of 4.8 nM, while the Maribavir-resistant UL97 mutant L397R shows reduced kinase activity to about 10% of the wild type. Enzyme kinetics reveal Maribavir acts as a competitive inhibitor of ATP with a Ki of 10 nM[1]. Additionally, Maribavir suppresses viral replication dose-dependently with an IC50 of 0.12±0.01 μM in multicycle DNA hybridization assays, and strongly inhibits the pUL97 protein kinase at a 50% inhibition concentration of 3 nM[2]. |
体外研究 | Maribavir effectively inhibits the autophosphorylation of both wild-type and major Ganciclovir (GCV) resistant UL97 mutants, with an average IC50 of 35 nM. The M460I mutation exhibits increased sensitivity to Maribavir, having an IC50 of 4.8 nM, while the Maribavir-resistant UL97 mutant L397R shows reduced kinase activity to about 10% of the wild type. Enzyme kinetics reveal Maribavir acts as a competitive inhibitor of ATP with a Ki of 10 nM[1]. Additionally, Maribavir suppresses viral replication dose-dependently with an IC50 of 0.12±0.01 μM in multicycle DNA hybridization assays, and strongly inhibits the pUL97 protein kinase at a 50% inhibition concentration of 3 nM[2]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00002373 | Cytomegalovirus Infections ... 展开 >> HIV Infections 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Univ of California/ San Francisco / Dept of Medicine San Francisco, California, United States, 94110 Dr Jacob Lalezari San Francisco, California, United States, 94115 收起 << |
NCT00411645 | Cytomegalovirus Infections | Phase 3 | Completed | - | - |
NCT00497796 | Cytomegalovirus Infections | Phase 3 | Completed | - | - |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.66mL 0.53mL 0.27mL |
13.29mL 2.66mL 1.33mL |
26.58mL 5.32mL 2.66mL |
CAS号 | 176161-24-3 |
分子式 | C15H19Cl2N3O4 |
分子量 | 376.235 |
别名 | GW257406X;1263W94;VP-41263;SHP-620;GW-1263;BW1263W94 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,2-8°C |
溶解度 |
DMSO: 190 mg/mL(505 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |